Skip to main content
Iclusig 15 mg/1 tablet, film coated by Takeda Pharmaceuticals America, Inc.
Iclusig, 15 mg/1, tablet, film coated Drug class: Kinase Inhibitor. Available on prescription only. Listed by Takeda Pharmaceuticals America, Inc..
Prescription only

Iclusig

ponatinib hydrochloride

Listed by Takeda Pharmaceuticals America, Inc.

Strength
15 mg/1
Form
Tablet, Film Coated
Route
Oral
Class
Kinase Inhibitor

What it contains

  • Ponatinib Hydrochloride 15 mg/1

FDA record

Dosage form Tablet, Film Coated
Route Oral
Drug class Kinase Inhibitor
Approval route NDA — original brand approval
NDC code 63020-535
FDA application NDA203469
Package sizes listed 2
Marketed since December 2012

Other products containing Ponatinib

See all

Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.

Iclusig

ponatinib hydrochloride

Strength
10 mg/1
Form
Tablet, Film Coated
Class
Kinase Inhibitor
Rx only

Takeda Pharmaceuticals America, Inc.

Not stocked by us — reference only

Iclusig

ponatinib hydrochloride

Strength
45 mg/1
Form
Tablet, Film Coated
Class
Kinase Inhibitor
Rx only

Takeda Pharmaceuticals America, Inc.

Not stocked by us — reference only

Iclusig

ponatinib hydrochloride

Strength
30 mg/1
Form
Tablet, Film Coated
Class
Kinase Inhibitor
Rx only

Takeda Pharmaceuticals America, Inc.

Not stocked by us — reference only

Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.